MDA SPACE LTD (MDA.CA) Fundamental Analysis & Valuation

TSX:MDA • CA55293N1096

Current stock price

39.68 CAD
-2.62 (-6.19%)
Last:

This MDA.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. MDA.CA Profitability Analysis

1.1 Basic Checks

  • In the past year MDA was profitable.
  • MDA had a positive operating cash flow in the past year.
  • Each year in the past 5 years MDA has been profitable.
  • Each year in the past 5 years MDA had a positive operating cash flow.
MDA.CA Yearly Net Income VS EBIT VS OCF VS FCFMDA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

1.2 Ratios

  • The Return On Assets of MDA (3.23%) is worse than 69.23% of its industry peers.
  • MDA's Return On Equity of 8.01% is amongst the best of the industry. MDA outperforms 84.62% of its industry peers.
  • The Return On Invested Capital of MDA (5.52%) is worse than 61.54% of its industry peers.
  • MDA had an Average Return On Invested Capital over the past 3 years of 4.56%. This is below the industry average of 8.83%.
  • The 3 year average ROIC (4.56%) for MDA is below the current ROIC(5.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.23%
ROE 8.01%
ROIC 5.52%
ROA(3y)2.85%
ROA(5y)2.05%
ROE(3y)6.45%
ROE(5y)4.45%
ROIC(3y)4.56%
ROIC(5y)3.69%
MDA.CA Yearly ROA, ROE, ROICMDA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 2 -2 4 6 8

1.3 Margins

  • Looking at the Profit Margin, with a value of 6.64%, MDA is doing worse than 61.54% of the companies in the same industry.
  • MDA's Profit Margin has improved in the last couple of years.
  • The Operating Margin of MDA (9.66%) is worse than 61.54% of its industry peers.
  • MDA's Operating Margin has declined in the last couple of years.
  • MDA has a Gross Margin of 25.09%. This is in the better half of the industry: MDA outperforms 61.54% of its industry peers.
  • In the last couple of years the Gross Margin of MDA has grown nicely.
Industry RankSector Rank
OM 9.66%
PM (TTM) 6.64%
GM 25.09%
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y17.44%
PM growth 5YN/A
GM growth 3Y-11.03%
GM growth 5Y9.6%
MDA.CA Yearly Profit, Operating, Gross MarginsMDA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. MDA.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MDA is destroying value.
  • The number of shares outstanding for MDA has been increased compared to 1 year ago.
  • The number of shares outstanding for MDA has been increased compared to 5 years ago.
  • Compared to 1 year ago, MDA has a worse debt to assets ratio.
MDA.CA Yearly Shares OutstandingMDA.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
MDA.CA Yearly Total Debt VS Total AssetsMDA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • MDA has an Altman-Z score of 2.20. This is not the best score and indicates that MDA is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 2.20, MDA belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
  • The Debt to FCF ratio of MDA is 3.11, which is a good value as it means it would take MDA, 3.11 years of fcf income to pay off all of its debts.
  • MDA has a better Debt to FCF ratio (3.11) than 92.31% of its industry peers.
  • MDA has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.29, MDA is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 3.11
Altman-Z 2.2
ROIC/WACC0.62
WACC8.97%
MDA.CA Yearly LT Debt VS Equity VS FCFMDA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 0.47 indicates that MDA may have some problems paying its short term obligations.
  • MDA has a worse Current ratio (0.47) than 92.31% of its industry peers.
  • MDA has a Quick Ratio of 0.47. This is a bad value and indicates that MDA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of MDA (0.45) is worse than 92.31% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.45
MDA.CA Yearly Current Assets VS Current LiabilitesMDA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. MDA.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 88.57% over the past year.
  • Measured over the past years, MDA shows a very strong growth in Earnings Per Share. The EPS has been growing by 81.71% on average per year.
  • MDA shows a strong growth in Revenue. In the last year, the Revenue has grown by 51.21%.
  • The Revenue has been growing by 40.76% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)88.57%
EPS 3Y81.71%
EPS 5YN/A
EPS Q2Q%73.08%
Revenue 1Y (TTM)51.21%
Revenue growth 3Y36.57%
Revenue growth 5Y40.76%
Sales Q2Q%44%

3.2 Future

  • MDA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.14% yearly.
  • MDA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.94% yearly.
EPS Next Y10.28%
EPS Next 2Y12.49%
EPS Next 3Y11.7%
EPS Next 5Y13.14%
Revenue Next Year13.44%
Revenue Next 2Y12.23%
Revenue Next 3Y11.26%
Revenue Next 5Y11.94%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MDA.CA Yearly Revenue VS EstimatesMDA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
MDA.CA Yearly EPS VS EstimatesMDA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

0

4. MDA.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • MDA is valuated quite expensively with a Price/Earnings ratio of 30.06.
  • Based on the Price/Earnings ratio, MDA is valued a bit more expensive than the industry average as 61.54% of the companies are valued more cheaply.
  • When comparing the Price/Earnings ratio of MDA to the average of the S&P500 Index (26.54), we can say MDA is valued inline with the index average.
  • A Price/Forward Earnings ratio of 27.26 indicates a quite expensive valuation of MDA.
  • MDA's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. MDA is more expensive than 69.23% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 21.68, MDA is valued a bit more expensive.
Industry RankSector Rank
PE 30.06
Fwd PE 27.26
MDA.CA Price Earnings VS Forward Price EarningsMDA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MDA indicates a slightly more expensive valuation: MDA is more expensive than 69.23% of the companies listed in the same industry.
  • 61.54% of the companies in the same industry are cheaper than MDA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 41.35
EV/EBITDA 19.91
MDA.CA Per share dataMDA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.92
PEG (5Y)N/A
EPS Next 2Y12.49%
EPS Next 3Y11.7%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MDA.CA Dividend Analysis

5.1 Amount

  • MDA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MDA.CA Fundamentals: All Metrics, Ratios and Statistics

MDA SPACE LTD

TSX:MDA (4/29/2026, 7:00:00 PM)

39.68

-2.62 (-6.19%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Industry Strength77.17
Industry Growth99.25
Earnings (Last)03-04
Earnings (Next)05-07
Inst Owners35.73%
Inst Owner ChangeN/A
Ins Owners1.23%
Ins Owner ChangeN/A
Market Cap5.46B
Revenue(TTM)1.63B
Net Income(TTM)108.50M
Analysts80
Price Target52.89 (33.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.65%
Min EPS beat(2)-40.3%
Max EPS beat(2)13%
EPS beat(4)3
Avg EPS beat(4)3.98%
Min EPS beat(4)-40.3%
Max EPS beat(4)22.16%
EPS beat(8)6
Avg EPS beat(8)11.19%
EPS beat(12)10
Avg EPS beat(12)26.46%
EPS beat(16)13
Avg EPS beat(16)60.97%
Revenue beat(2)2
Avg Revenue beat(2)3.42%
Min Revenue beat(2)0.35%
Max Revenue beat(2)6.49%
Revenue beat(4)3
Avg Revenue beat(4)3.37%
Min Revenue beat(4)-0.24%
Max Revenue beat(4)6.87%
Revenue beat(8)6
Avg Revenue beat(8)3.52%
Revenue beat(12)9
Avg Revenue beat(12)2.95%
Revenue beat(16)12
Avg Revenue beat(16)2.63%
PT rev (1m)9.74%
PT rev (3m)29.81%
EPS NQ rev (1m)3.33%
EPS NQ rev (3m)-9.71%
EPS NY rev (1m)-3.76%
EPS NY rev (3m)-5.8%
Revenue NQ rev (1m)0.18%
Revenue NQ rev (3m)-2.23%
Revenue NY rev (1m)2.35%
Revenue NY rev (3m)1.44%
Valuation
Industry RankSector Rank
PE 30.06
Fwd PE 27.26
P/S 3.34
P/FCF 41.35
P/OCF 13.41
P/B 4.03
P/tB N/A
EV/EBITDA 19.91
EPS(TTM)1.32
EY3.33%
EPS(NY)1.46
Fwd EY3.67%
FCF(TTM)0.96
FCFY2.42%
OCF(TTM)2.96
OCFY7.46%
SpS11.86
BVpS9.84
TBVpS-2.34
PEG (NY)2.92
PEG (5Y)N/A
Graham Number17.0973 (-56.91%)
Profitability
Industry RankSector Rank
ROA 3.23%
ROE 8.01%
ROCE 7.74%
ROIC 5.52%
ROICexc 5.97%
ROICexgc 53.8%
OM 9.66%
PM (TTM) 6.64%
GM 25.09%
FCFM 8.09%
ROA(3y)2.85%
ROA(5y)2.05%
ROE(3y)6.45%
ROE(5y)4.45%
ROIC(3y)4.56%
ROIC(5y)3.69%
ROICexc(3y)4.93%
ROICexc(5y)3.95%
ROICexgc(3y)28.38%
ROICexgc(5y)20.74%
ROCE(3y)6.39%
ROCE(5y)5.17%
ROICexgc growth 3Y61.99%
ROICexgc growth 5YN/A
ROICexc growth 3Y16.02%
ROICexc growth 5YN/A
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y17.44%
PM growth 5YN/A
GM growth 3Y-11.03%
GM growth 5Y9.6%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 3.11
Debt/EBITDA 1.31
Cap/Depr 195.88%
Cap/Sales 16.86%
Interest Coverage 10.52
Cash Conversion 136.56%
Profit Quality 121.75%
Current Ratio 0.47
Quick Ratio 0.45
Altman-Z 2.2
F-Score5
WACC8.97%
ROIC/WACC0.62
Cap/Depr(3y)221.3%
Cap/Depr(5y)203.76%
Cap/Sales(3y)19.79%
Cap/Sales(5y)21.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.57%
EPS 3Y81.71%
EPS 5YN/A
EPS Q2Q%73.08%
EPS Next Y10.28%
EPS Next 2Y12.49%
EPS Next 3Y11.7%
EPS Next 5Y13.14%
Revenue 1Y (TTM)51.21%
Revenue growth 3Y36.57%
Revenue growth 5Y40.76%
Sales Q2Q%44%
Revenue Next Year13.44%
Revenue Next 2Y12.23%
Revenue Next 3Y11.26%
Revenue Next 5Y11.94%
EBIT growth 1Y47.75%
EBIT growth 3Y28.37%
EBIT growth 5YN/A
EBIT Next Year120.8%
EBIT Next 3Y40.41%
EBIT Next 5Y28.09%
FCF growth 1Y-78.51%
FCF growth 3YN/A
FCF growth 5Y25.11%
OCF growth 1Y-50.04%
OCF growth 3Y92.64%
OCF growth 5Y48.51%

MDA SPACE LTD / MDA.CA Fundamental Analysis FAQ

What is the fundamental rating for MDA stock?

ChartMill assigns a fundamental rating of 4 / 10 to MDA.CA.


Can you provide the valuation status for MDA SPACE LTD?

ChartMill assigns a valuation rating of 0 / 10 to MDA SPACE LTD (MDA.CA). This can be considered as Overvalued.


How profitable is MDA SPACE LTD (MDA.CA) stock?

MDA SPACE LTD (MDA.CA) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for MDA stock?

The Price/Earnings (PE) ratio for MDA SPACE LTD (MDA.CA) is 30.06 and the Price/Book (PB) ratio is 4.03.


Can you provide the expected EPS growth for MDA stock?

The Earnings per Share (EPS) of MDA SPACE LTD (MDA.CA) is expected to grow by 10.28% in the next year.